Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm.

British journal of haematology - 1 Jun 1990

Taylor S A, Liddell M B, Peake I R, Bloom A L, Lillicrap D P

Abstract excerpt

The genetic basis of a mild form of haemophilia Bm has been investigated. The patient under investigation has a mild bleeding disorder and has never experienced spontaneous bleeds. Factor IX coagulant activity (FIX:C) was 0.15 units/ml and factor IX antigen (FIX:Ag) 1.32 units/ml. The prothrombin time performed with an ox brain thromboplastin was 65 s (normal plasma 31 s). Studies of the abnormal factor IX...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Blood Coagulation
Share to Factor IX

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hemophilia B

Share to Immunoblotting

Share to Mutation

Share to Nucleic Acid Amplification Techniques

Share to Valine

Source

Identifiers

PMID: 2372509
DOI: 10.1111/j.1365-2141.1990.tb02652.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm.PMID 2372509Read ↗

Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.Semantic proximity Read ↗

Mutations in the catalytic domain of factor IX that are related to the subclass hemophilia Bm.Semantic proximity Read ↗

Amino acid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild and moderately severe hemophilia A.Semantic proximity Read ↗

The molecular basis of haemophilia B.Semantic proximity Read ↗

Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V geneSemantic proximity Read ↗

Phenotypic characterization of haemophilia B – Understanding the underlying biology of coagulation factor IXSemantic proximity Read ↗

R924Q substitution encoded within exon 21 of the von Willebrand factor gene related to mild bleeding phenotype.Semantic proximity Read ↗

Twenty-five novel mutations of the factor IX gene in haemophilia B.Semantic proximity Read ↗

Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide.Semantic proximity Read ↗

Factor IX propeptide mutation and life threatening bleeding.Semantic proximity Read ↗

Clinical significance of two mutations in the factor IX gene in a family with haemophilia B.Semantic proximity Read ↗

Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.